Universitätsklinikum Hamburg-Eppendorf

The Universitätsklinikum Hamburg‑Eppendorf conducts trials focused on improving outcomes for children with high‑risk neuroblastoma, evaluating intensive chemotherapy regimens and advanced radiation strategies.

• High‑dose chemotherapy sequencing
• Radiotherapy dose escalation
• Chemo‑immunotherapy combinations
• Metastatic response evaluation

The goal is to increase event‑free survival and refine treatment protocols for this aggressive pediatric cancer.

Researchers are testing a biomarker‑directed approach to personalize therapy for patients with chronic kidney disease, aiming to preserve kidney function over time.

• Biomarker identification and validation
• Targeted treatment selection
• Monitoring eGFR trajectory
• Optimizing long‑term renal outcomes

This study seeks to demonstrate that tailored interventions can slow disease progression compared with standard care.